162 related articles for article (PubMed ID: 22226043)
1. Estrogen receptor alpha deletion enhances the metastatic phenotype of Ron overexpressing mammary tumors in mice.
Marshall AM; McClaine RJ; Gurusamy D; Gray JK; Lewnard KE; Khan SA; Waltz SE
Mol Cancer; 2012 Jan; 11():2. PubMed ID: 22226043
[TBL] [Abstract][Full Text] [Related]
2. Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation.
Zinser GM; Leonis MA; Toney K; Pathrose P; Thobe M; Kader SA; Peace BE; Beauman SR; Collins MH; Waltz SE
Cancer Res; 2006 Dec; 66(24):11967-74. PubMed ID: 17178895
[TBL] [Abstract][Full Text] [Related]
3. Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.
Wagh PK; Zinser GM; Gray JK; Shrestha A; Waltz SE
Endocrinology; 2012 Jun; 153(6):2735-46. PubMed ID: 22474186
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.
Johnson AL; Zinser GM; Waltz SE
Oncotarget; 2015 Jun; 6(18):16304-20. PubMed ID: 26008979
[TBL] [Abstract][Full Text] [Related]
5. Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines.
McClaine RJ; Marshall AM; Wagh PK; Waltz SE
Neoplasia; 2010 Aug; 12(8):650-8. PubMed ID: 20689759
[TBL] [Abstract][Full Text] [Related]
6. Chk2*1100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in mice.
Meyer SE; Peace BE; Bahassi el M; Kavanaugh GM; Wagh PK; Robbins SB; Yin M; Wells SI; Zinser GM; Stambrook PJ; Waltz SE
Cancer Lett; 2010 Oct; 296(2):186-93. PubMed ID: 20434834
[TBL] [Abstract][Full Text] [Related]
7. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
[TBL] [Abstract][Full Text] [Related]
8. Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancer.
Peace BE; Toney-Earley K; Collins MH; Waltz SE
Cancer Res; 2005 Feb; 65(4):1285-93. PubMed ID: 15735014
[TBL] [Abstract][Full Text] [Related]
9. HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses.
Benight NM; Wagh PK; Zinser GM; Peace BE; Stuart WD; Vasiliauskas J; Pathrose P; Starnes SL; Waltz SE
Oncotarget; 2015 Jul; 6(19):17445-61. PubMed ID: 25938541
[TBL] [Abstract][Full Text] [Related]
10. β-Catenin is required for Ron receptor-induced mammary tumorigenesis.
Wagh PK; Gray JK; Zinser GM; Vasiliauskas J; James L; Monga SP; Waltz SE
Oncogene; 2011 Aug; 30(34):3694-704. PubMed ID: 21423209
[TBL] [Abstract][Full Text] [Related]
11. Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.
Johnstone CN; Smith YE; Cao Y; Burrows AD; Cross RS; Ling X; Redvers RP; Doherty JP; Eckhardt BL; Natoli AL; Restall CM; Lucas E; Pearson HB; Deb S; Britt KL; Rizzitelli A; Li J; Harmey JH; Pouliot N; Anderson RL
Dis Model Mech; 2015 Mar; 8(3):237-51. PubMed ID: 25633981
[TBL] [Abstract][Full Text] [Related]
12. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.
Ramamoorthy S; Tufail R; Hokayem JE; Jorda M; Zhao W; Reis Z; Nawaz Z
Breast Cancer Res Treat; 2012 Feb; 132(1):97-108. PubMed ID: 21553290
[TBL] [Abstract][Full Text] [Related]
14. The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers.
Privette Vinnedge LM; Benight NM; Wagh PK; Pease NA; Nashu MA; Serrano-Lopez J; Adams AK; Cancelas JA; Waltz SE; Wells SI
Oncogene; 2015 Apr; 34(18):2325-36. PubMed ID: 24954505
[TBL] [Abstract][Full Text] [Related]
15. RON, a tyrosine kinase receptor involved in tumor progression and metastasis.
Camp ER; Liu W; Fan F; Yang A; Somcio R; Ellis LM
Ann Surg Oncol; 2005 Apr; 12(4):273-81. PubMed ID: 15827676
[TBL] [Abstract][Full Text] [Related]
16. Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.
Wagh PK; Peace BE; Waltz SE
Adv Cancer Res; 2008; 100():1-33. PubMed ID: 18620091
[TBL] [Abstract][Full Text] [Related]
17. Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice.
Cornelissen LM; Henneman L; Drenth AP; Schut E; de Bruijn R; Klarenbeek S; Zwart W; Jonkers J
J Mammary Gland Biol Neoplasia; 2019 Dec; 24(4):305-321. PubMed ID: 31729597
[TBL] [Abstract][Full Text] [Related]
18. DNA Methylation Status of the Estrogen Receptor α Gene in Canine Mammary Tumors.
Brandão YO; Toledo MB; Chequin A; Cristo TG; Sousa RS; Ramos EAS; Klassen G
Vet Pathol; 2018 Jul; 55(4):510-516. PubMed ID: 29566609
[TBL] [Abstract][Full Text] [Related]
19. Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling.
Bourn JR; Ruiz-Torres SJ; Hunt BG; Benight NM; Waltz SE
Cancer Lett; 2021 Apr; 503():75-90. PubMed ID: 33508385
[TBL] [Abstract][Full Text] [Related]
20. Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.
Barcus CE; O'Leary KA; Brockman JL; Rugowski DE; Liu Y; Garcia N; Yu M; Keely PJ; Eliceiri KW; Schuler LA
Breast Cancer Res; 2017 Jan; 19(1):9. PubMed ID: 28103936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]